“`html

UAB Researchers Secure Funding for Mitochondrial and Parkinson’s Disease Research

Researchers Albert Quintana and Salvador Ventura at the Universitat Autònoma de Barcelona (UAB) are leading two research projects that received funding in the 8th Call for Health Research from the “la Caixa” Foundation. These projects aim to develop innovative approaches to improve treatment for mitochondrial diseases and Parkinson’s disease, respectively.

the “la Caixa” Foundation Health Research Call

The 2025 Call for Health Research from the “la Caixa” Foundation selected 34 cutting-edge biomedical research projects from a pool of 714 submissions. These winning projects will be conducted across 25 research centers, universities, and hospitals in Spain, and 9 in Portugal. The total funding allocated through this program is 26 million euros (“la Caixa” Foundation Health Research Call 2025 Results).

Project Details: Mitochondrial Diseases

Led by Albert Quintana, this project focuses on mitochondrial diseases. Mitochondria are often called the “powerhouses of the cell” because they generate most of the cell’s energy. Mitochondrial diseases occur when these organelles don’t function properly, leading to a wide range of health problems. Quintana’s research aims to identify new therapeutic targets and strategies for these debilitating conditions.

Understanding Mitochondrial Diseases

Mitochondrial diseases are frequently enough genetic, meaning they are caused by defects in genes that control mitochondrial function. These diseases can affect any organ system, but commonly impact those with high energy demands, such as the brain, heart, and muscles. Currently, treatment options are limited, making research like Quintana’s crucial.

Project Details: Parkinson’s Disease

The project led by Salvador Ventura investigates Parkinson’s disease.Parkinson’s is a progressive neurodegenerative disorder that affects movement. Ventura’s research explores novel mechanisms underlying the disease and seeks to develop new therapies to slow or halt its progression.

Parkinson’s Disease: A Deeper Look

Parkinson’s disease is characterized by the loss of dopamine-producing neurons in the brain. While the exact cause is often unknown, genetic and environmental factors are believed to play a role. Symptoms typically develop slowly, starting with tremors, rigidity, and slow movement. Ventura’s work aims to address the underlying causes of neuronal loss in Parkinson’s.

Key takeaways

• Two UAB research projects received funding from the “la Caixa” Foundation’s 2025 Health research Call.
• The projects focus on developing innovative treatments for mitochondrial diseases and Parkinson’s disease.
• The total funding awarded to the UAB projects is part of a larger 26 million euro investment in biomedical research.
• Researchers Albert Quintana and Salvador Ventura are leading these critical investigations.

This funding represents a significant boost for biomedical research at the UAB and offers hope for improved treatments for individuals affected by these challenging diseases.Continued research in these areas is vital for developing effective therapies and improving the quality of life for patients and their families.

Publication Date: 2025/11/20 12:51:28